sever
acut
respiratori
syndrom
sar
outbreak
high
morbid
rate
caus
worldwid
alarm
remain
untreat
today
even
though
sar
eventu
isol
control
develop
highthroughput
screen
efficaci
drug
therefor
critic
howev
current
remain
lack
safe
system
gener
character
first
select
sarscoronaviru
sarscov
base
replicon
cell
line
use
screen
describ
partial
sarscov
cdna
antibiot
resistancereport
gene
dna
gener
assembl
vitro
produc
replicon
transcript
templat
transcrib
vitro
gener
replicon
rna
latter
introduc
mammalian
cell
line
transfect
cell
select
antibiot
applic
antibioticresist
cell
line
thu
gener
express
report
gene
ensur
continu
monitor
use
fluoresc
microscopi
flow
cytometri
suitabl
replicon
cell
line
drug
screen
demonstr
test
inhibitori
effect
sever
exist
drug
result
demonstr
sarscov
replicon
cell
line
provid
safe
tool
identif
sarscov
replicas
inhibitor
replicon
cell
line
thu
develop
appli
highthroughput
screen
antisar
drug
without
need
grow
infecti
sarscov
sever
acut
respiratori
syndrom
sar
potenti
fatal
atyp
pneumonia
aros
guangdong
provinc
peopl
republ
china
novemb
quickli
spread
countri
five
differ
contin
caus
largescal
outbreak
hong
kong
singapor
toronto
earli
peiri
et
al
sar
recogn
late
end
viral
outbreak
juli
sar
case
report
worldwid
sarsattribut
death
outbreak
sever
profound
impact
public
health
economi
worldwid
remind
us
danger
emerg
infecti
diseas
bring
dens
popul
societi
coronavirus
order
nidoviral
famili
coronavirida
genu
coronaviru
group
virus
larg
envelop
crownlik
virion
positivesens
singlestrand
rna
genom
siddel
et
al
genom
coronavirus
rang
kb
largest
known
rna
virus
coronavirus
share
characterist
cotermin
nestedset
structur
subgenom
rna
addit
uniqu
rna
synthesi
strategi
genom
organ
nucleotid
sequenc
homolog
structur
protein
particular
coronavirus
cavanagh
et
al
etiolog
agent
sar
identifi
novel
coronaviru
sarscov
peiri
et
al
drosten
et
al
ksiazek
et
al
poutanen
et
al
although
genom
sequenc
sarscov
resembl
three
recogn
group
coronavirus
soon
diseas
recogn
sarscov
confirm
caus
agent
sar
demonstr
coronaviru
could
use
experiment
infect
induc
interstiti
pneumon
cynomolgu
macaqu
thu
fulfil
koch
postul
kuiken
et
al
although
sar
epidem
eventu
control
patient
isol
neither
effect
treatment
sar
present
efficaci
vaccin
prevent
infect
peiri
et
al
signific
morbid
mortal
includ
potenti
reemerg
make
necessari
develop
effect
method
treat
prevent
diseas
therefor
fight
sar
import
develop
antivir
agent
specif
inhibit
rna
synthesi
sarscov
maxim
chanc
find
efficaci
antisar
drug
highthroughput
screen
larg
chemic
librari
compound
block
sarscov
replic
must
carri
howev
high
infect
virul
sarscov
render
kind
research
danger
therefor
need
antivir
agent
identif
system
involv
use
live
viru
aim
partial
viral
rna
genom
construct
replic
persist
divid
cell
without
produc
viral
particl
kaplan
racaniello
liljestrom
garoff
khromykh
westaway
behren
et
al
lohmann
et
al
pang
et
al
shi
et
al
thumfart
meyer
hertzig
et
al
viral
replicon
deriv
viral
genom
delet
structur
gene
due
absenc
viral
structur
gene
virion
protein
synthes
cell
therefor
infecti
viral
particl
could
produc
cell
howev
sinc
transand
cisact
compon
requir
viral
rna
synthesi
retain
partial
viral
rna
could
replic
autonom
cell
report
describ
construct
first
sarscovderiv
replicon
cell
line
sarsassoci
replicon
cell
line
base
use
sar
replicon
cdna
gener
revers
genet
techniqu
result
demonstr
sarscovderiv
replicon
cell
line
use
test
candid
sarscov
replicas
inhibitor
without
need
grow
infecti
sarscov
method
develop
replicon
construct
base
strategi
previous
use
assembl
fulllength
cdna
construct
sarscov
yount
et
al
strategi
construct
replicon
illustr
fig
viral
envelopeprotein
code
gene
e
exclud
replicon
disabl
virion
synthesi
product
secret
nucleocapsid
gene
n
retain
nucleocapsid
protein
shown
requir
viral
rna
synthesi
almazan
et
al
hertzig
et
al
sequenc
involv
regul
express
coronaviru
gene
nt
upstream
gene
alonso
et
al
jeong
et
al
therefor
achiev
rel
nativ
express
n
gene
replicon
region
nt
upstream
n
orf
includ
replicon
green
fluoresc
proteinblasticidin
deaminas
fusion
gfpblar
gene
also
includ
replicon
enabl
easi
select
detect
repliconcontain
cell
gfpblar
gene
insert
orf
n
end
replicon
order
minim
possibl
deleteri
effect
synthesi
replicon
rna
express
gfpblar
driven
transcript
regulatori
sequenc
orf
includ
replicon
occur
posit
right
upstream
gfpblar
gene
follow
strategi
six
cdna
subclon
span
sarscov
genom
use
assembl
recombin
sarscov
replicon
cdna
green
fluoresc
proteinblasticidin
deaminas
fusion
gb
gene
amplifi
plasmid
bsdlacz
use
pcr
includ
replicon
construct
addit
cdna
construct
flank
restrict
site
leav
uniqu
interconnect
junction
nt
length
sapi
bsai
sticki
end
complementari
major
sticki
end
gener
enzym
site
dna
replicon
cdna
systemat
assembl
vitro
ligat
total
dna
ligat
reaction
extract
use
phenolchloroform
use
directli
templat
vitro
transcript
synthesi
sarscov
replicon
rna
rough
qualiti
inspect
aliquot
posttranscript
mixtur
analyz
denatur
agaros
gel
transcript
seen
appropri
length
data
shown
purifi
sarscov
replicon
rna
use
transfect
cell
transfect
cell
subject
blasticidin
select
enrich
repliconcarri
cell
fluoresc
indic
success
transfect
select
sarscov
replicon
rna
transfect
cell
observ
fluoresc
microscop
day
blasticidin
treatment
cluster
greenfluoresc
cell
observ
typic
greenfluoresc
cell
cluster
shown
fig
observ
sign
cytotox
due
sarscov
replicon
morpholog
greenfluoresc
cell
typic
cell
transfect
cultur
maintain
blasticidin
select
obtain
cell
carri
sarscov
replicon
consist
autonom
replic
viral
rna
also
success
maintain
northern
blot
analysi
total
cellular
rna
prepar
reveal
presenc
fulllength
replicon
rna
replicon
rna
deriv
transcript
encod
gb
n
gene
n
gene
probe
detect
replicon
rna
replicon
rnaderiv
gbn
n
rna
gb
probe
detect
rna
contain
gb
gene
replicon
rna
replicon
rnaderiv
gbn
mrna
fig
gfp
express
studi
fluoresc
microscopi
flow
cytometri
period
month
passag
blasticidin
select
shown
fig
averag
green
fluoresc
intens
valu
cultur
remain
constant
level
excess
parent
cultur
result
consist
compar
previou
find
hertzig
et
al
hertzig
et
al
analyz
gfp
express
hcov
replicon
cell
flow
cytometri
period
month
passag
select
show
percentag
green
fluoresc
cell
remain
constant
level
throughout
period
thu
data
indic
although
replicon
cell
may
express
suffici
gfpblar
surviv
blasticidin
select
amount
gfp
blar
protein
insuffici
detect
flow
cytometri
possibl
caus
differenti
gfp
blar
protein
express
replicon
cell
effici
function
replicon
rna
uptak
transfect
thu
analysi
show
sarscov
replicon
persist
effici
grow
consist
cell
select
substanti
period
time
would
suitabl
use
antisar
drug
screen
purpos
furthermor
cell
store
month
liquid
nitrogen
recultur
still
display
green
fluoresc
indistinguish
cell
passag
continu
data
shown
subsequ
passag
cell
cultur
supernat
onto
cell
also
result
either
blasticidin
resist
gfp
express
thu
demonstr
replicon
particl
releas
passag
supernat
fresh
cultur
sequenc
analysi
replicon
rna
purifi
cell
soon
select
blasticidin
passag
number
found
sequenc
differ
compar
publish
sequenc
sarscov
strain
genbank
access
number
passag
number
rna
cell
purifi
examin
sequenc
analysi
later
passag
three
nucleotid
chang
detect
result
three
amino
acid
chang
two
orf
one
n
gene
tabl
sinc
nucleotid
chang
encod
clone
cdna
adapt
mutat
occur
earli
passag
three
mutat
like
acquir
replic
later
passag
remain
import
elucid
whether
mutat
facilit
effici
replic
replicon
rna
develop
fast
conveni
antivir
screen
protocol
detect
sarscov
replicas
inhibitor
three
previous
describ
antivir
drug
test
evalu
context
sarscov
inhibit
tissu
cultur
yount
et
al
cinatl
et
al
et
al
compound
appli
differ
concentr
cell
gfp
express
monitor
flow
cytometri
analysi
fluoresc
microscopi
quantit
realtim
pcr
day
later
untreat
cell
serv
control
cytotox
effect
compound
assess
parallel
parent
cell
shown
fig
incub
cell
mgml
reduc
level
report
gene
express
copi
number
replicon
rna
also
overal
percentag
green
fluoresc
cell
importantli
cytotox
observ
near
inhibitori
concentr
ribavirin
show
low
inhibitori
activ
concentr
mgml
signific
cytotox
effect
observ
higher
concentr
mgml
ribavirin
consid
inact
sarscov
replic
glycyrrhizin
show
low
inhibitori
effect
concentr
mgml
result
indic
cystein
proteinas
inhibitor
appear
repres
promis
candid
inhibit
sarscov
replicas
function
hand
therapeut
efficaci
drug
may
limit
low
specif
inhibitori
effect
signific
cytotox
taken
togeth
result
show
replicon
cell
line
thu
develop
would
use
antisar
drug
screen
provid
tool
studi
candid
antisar
agent
past
year
concept
autonom
replic
rna
replicon
rna
appli
number
positivestrand
rna
viru
system
led
establish
novel
antivir
screen
assay
vector
bartenschlag
lo
et
al
baric
group
construct
transmiss
gastroenter
viru
tgev
replicon
express
heterolog
gfp
gene
curti
et
al
thiel
group
gener
noncytopath
select
replicon
rna
base
hcov
identif
coronaviru
replicas
inhibitor
hertzig
et
al
nevertheless
genom
sequenc
data
sarscov
reveal
novel
agent
belong
known
group
coronavirus
includ
two
human
coronavirus
hcov
hcov
peiri
et
al
drosten
et
al
therefor
despit
presenc
function
replicon
rna
assay
hertzig
et
al
need
develop
sarscov
replicon
cell
line
would
allow
rapid
safe
identif
inhibitor
specif
sarscov
studi
first
select
sarscov
base
replicon
cell
line
success
establish
character
purpos
screen
antisar
drug
sarscov
replicon
cell
line
describ
valuabl
tool
develop
antisar
therapeut
result
follow
replicas
inhibitor
clearli
demonstr
sarscov
replicon
system
facilit
identif
inhibitor
tissu
cultur
replicas
inhibitor
ribavirin
although
activ
wide
rang
virus
use
sar
therapi
et
al
shown
studi
inact
sarscov
vitro
noncytotox
concentr
line
previou
report
tan
et
al
cinatl
et
al
wu
et
al
next
find
inhibitor
select
activ
sarscov
line
studi
yount
et
al
show
effect
inhibit
sarscov
replic
tissu
cultur
glycyrrhizin
variat
result
obtain
studi
compar
previous
publish
result
may
due
assay
condit
includ
viru
strain
detect
method
compound
concentr
handl
cinatl
et
al
notabl
independ
group
also
observ
lack
antisarscov
activ
glycyrrhizin
hertzig
et
al
indic
glycyrrhizin
may
inhibit
coronaviru
replic
instead
exert
antivir
effect
viru
adsorpt
releas
easili
detect
gfp
express
absenc
virion
product
viral
replicon
cell
line
repres
simpler
safer
system
antivir
agent
identif
live
viru
infect
system
thu
efficaci
candid
inhibitor
evalu
measur
fluoresc
intens
replicon
cell
addit
drug
mean
cellbas
system
easili
autom
use
largescal
screen
antisarscov
agent
furthermor
viral
replicon
cellbas
system
use
test
individu
antivir
agent
design
base
certain
biochem
principl
new
drug
target
multipl
region
sarscov
orf
n
gene
sinc
infecti
viru
form
assay
repres
safe
protocol
perform
biosafeti
level
laboratori
compar
antivir
agent
identif
system
base
purifi
protein
nucleic
acid
sarscov
replicon
cell
line
two
advantag
first
candid
inhibitor
inhibit
replic
replicon
rna
occur
intracellularli
thu
demonstr
agent
permeat
cell
secondli
cytotox
candid
inhibitor
also
observ
simultan
note
cell
morpholog
two
critic
index
candid
inhibitorit
inhibitori
effect
cytotox
therefor
met
use
sarscov
replicon
cell
line
antivir
agent
identifi
use
purifiedbimolecularbas
system
test
cell
deliveri
cytotox
agent
done
separ
disadvantag
replicon
cellbas
system
structur
gene
e
includ
replicon
rna
therefor
use
screen
drug
act
cellular
viral
target
involv
receptor
bind
viru
entri
genom
encapsul
viru
releas
howev
structur
gene
coronavirus
chang
rapidli
antivir
agent
target
gene
less
consist
efficaci
thu
antivir
agent
target
region
highli
conserv
coronaviru
genom
orf
conserv
region
found
conclus
replicon
system
provid
conveni
safe
screen
system
identif
drug
candid
select
activ
sarscov
protocol
reagent
develop
studi
use
gain
insight
mechan
rna
synthesi
pathogen
potenti
addit
applic
includ
develop
rna
vaccin
sarscov
rna
vector
longterm
gene
express
babi
hamster
kidney
bhk
cell
line
purchas
american
typic
cultur
center
atcc
cell
line
maintain
dmem
medium
gibco
supplement
foetal
calf
serum
gibco
sarscov
strain
virion
rna
gift
prof
k
chow
depart
microbiolog
nation
univers
singapor
use
templat
cdna
synthesi
revers
genet
strategi
construct
desir
sarscov
replicon
illustr
fig
revers
transcript
reaction
perform
use
superscript
iii
first
strand
kit
invitrogen
describ
manufactur
manual
modif
nathan
et
al
revers
transcript
prime
use
oligonucleotid
attgtcctccac
ttgc
cdna
denatur
amplifi
pcr
elongas
amplif
system
invitrogen
cycl
min
depend
size
amplicon
amplicon
isol
agaros
gel
clone
topo
ii
ta
vector
invitrogen
accord
manufactur
direct
follow
primer
use
isol
sar
subclon
froward
revers
subclon
forward
revers
b
subclon
froward
revers
c
subclon
froward
revers
subclon
froward
revers
n
subclon
froward
revers
gb
dna
amplifi
describ
except
templat
vector
dna
ng
primer
forward
revers
two
five
independ
clone
sar
amplicon
isol
sequenc
use
panel
primer
locat
kb
sar
insert
abi
model
autom
sequenc
sequenc
data
thu
obtain
compar
publish
sequenc
sarscov
strain
genbank
access
number
use
megalign
modul
sequenc
analysi
softwar
lasergen
dnastar
consensu
sequenc
clone
fragment
determin
necessari
ie
b
subclon
consensu
clone
assembl
use
restrict
enzym
standard
recombin
dna
techniqu
remov
unwant
amino
acid
chang
except
silent
mutat
plasmid
grown
high
concentr
isol
digest
doubledigest
sapi
bsai
accord
manufactur
direct
neb
appropri
size
cdna
insert
isol
agaros
gel
extract
use
qiaex
ii
dna
purif
kit
qiagen
b
c
gb
n
fragment
ligat
overnight
isol
cd
gbn
cdna
ligat
overnight
result
dna
extract
first
phenolchloroformisoamyl
alcohol
chloroform
precipit
presenc
ethanol
sodium
acet
ph
shortli
perform
vitro
transcript
see
extract
dna
pellet
centrifug
wash
ethanol
airdri
final
dissolv
rnasefre
water
detail
clone
strategi
plasmid
map
sequenc
avail
author
upon
request
vitro
transcript
system
mmessag
mmachin
kit
ambion
also
includ
rna
function
use
gener
sarscov
replicon
rna
h
reaction
mix
perform
mm
gtp
stock
result
ratio
gtp
cap
analog
remov
dna
templat
dnase
ad
reaction
mix
incub
min
polyadenyl
rna
synthes
reaction
mixtur
treat
reagent
poli
tail
kit
ambion
final
product
purifi
ad
licl
precipit
solut
ambion
pellet
rna
rna
wash
ml
ethanol
airdri
final
dissolv
rnasefre
water
cell
grown
confluenc
plate
transfect
sarscov
replicon
rna
transfect
agent
lipofectamin
invitrogen
optimem
medium
invitrogen
accord
manufactur
instruct
one
day
transfect
blasticidin
invitrogen
ad
final
concentr
cultur
medium
select
repliconcarri
cell
two
week
later
individu
cell
clone
isol
expand
analysi
storag
liquid
nitrogen
blasticidinresist
cell
line
gener
design
subject
analys
pertin
sarscov
replicon
carri
parent
cell
line
use
neg
control
analys
fluoresc
microscopi
flow
cytometri
use
observ
green
fluoresc
gfp
blar
protein
express
sarscov
replicon
cell
observ
olympu
invert
fluoresc
microscop
imag
record
use
imagepro
plu
media
cybernet
cell
scan
green
fluoresc
light
scatter
use
beckman
coulter
epic
altra
flow
cytomet
data
collect
analyz
use
winmdi
data
analysi
program
scripp
research
institut
analyz
whether
introduc
replicon
rna
mediat
coronavirusspecif
discontinu
transcript
lgbn
ln
mrna
fig
northern
blot
analysi
perform
northern
blot
analysi
total
cellular
rna
cell
isol
use
rneasi
mini
kit
qiagen
accord
anim
cell
protocol
suppli
manufactur
sampl
total
cellular
rna
denatur
electropor
transfer
hybondn
posit
charg
nylon
membran
ambion
per
manufactur
instruct
hybrid
fluoresceinlabel
probe
specif
gb
gene
sar
n
gene
gb
n
probe
prepar
gb
n
gene
use
gene
imag
random
prime
label
modul
amersham
hybrid
probe
immobil
rna
nylon
membran
subsequ
signal
gener
done
use
reagent
gene
imag
cdpstar
detect
modul
amersham
chemiluminesc
signal
fig
gener
subreplicon
rna
discontinu
transcript
sarscov
replicon
rna
repliconcarri
cell
black
box
repres
leader
rna
sequenc
deriv
end
replicon
locat
end
subreplicon
rna
size
rna
shown
exclus
polya
tail
emit
blot
detect
expos
hyperfilmmp
xray
film
amersham
blot
durat
min
follow
photograph
develop
expos
film
obtain
complet
sequenc
sarscov
replicon
persist
cell
total
cellular
rna
isol
cell
passag
number
use
templat
rna
amplifi
rtpcr
pcr
product
gelpurifi
sequenc
directli
primer
use
rtpcr
sequenc
analysi
avail
upon
request
prove
replicon
particl
releas
passag
supernat
fresh
cultur
supernat
obtain
cell
cultur
passag
onto
fresh
cell
examin
blasticidin
resist
gfp
express
identifi
potenti
agent
activ
sarscov
replic
three
drug
approv
clinic
use
treatment
viral
infect
test
glycyrrhizin
sigma
includ
test
due
previous
report
activ
sarscov
replic
yount
et
al
cinatl
et
al
ribavirin
icn
pharma
also
use
repres
wide
use
class
nucleosid
analog
inhibit
viral
polymeras
et
al
cell
cultur
plate
dmem
contain
fb
blasticidin
cultur
media
remov
incub
cell
reach
confluenc
replac
fresh
medium
without
blasticidin
grade
dose
drug
ad
monolay
cell
untreat
well
serv
control
three
day
later
cell
harvest
analyz
fluoresc
microscopi
flow
cytometri
four
duplic
test
perform
inhibit
report
gene
express
calcul
reduct
fluoresc
intens
gfpposit
cell
set
fluoresc
intens
untreat
cell
parallel
cytotox
drug
assay
cell
use
celltit
aqueou
nonradioact
cell
prolifer
assay
kit
promega
realtim
rtpcr
analys
perform
quantifi
copi
number
replicon
rna
cell
drug
treatment
total
cellular
rna
cell
isol
use
rneasi
mini
kit
onestep
artu
sar
lc
rtpcr
kit
qiagen
hamburg
germani
use
realtim
quantit
amplif
sarscov
replicon
rna
real
time
rtpcr
perform
accord
instruct
manufactur
amplicon
primer
describ
briefli
total
rna
extract
ad
capillari
tube
contain
rtpcr
reagent
load
lightcycl
roch
diagnost
gmbh
mannheim
germani
thermal
cycl
condit
follow
rt
perform
min
amplif
perform
cycl
follow
cycl
denatur
anneal
extens
final
cool
perform
total
rna
extract
cell
use
neg
control
intern
sarscov
standard
allow
determin
copi
number
replicon
rna
suppli
assay
kit
realtim
pcr
signal
analyz
use
lightcycl
softwar
roch
version
size
uniqu
pcr
product
verifi
perform
melt
curv
agaros
gel
electrophoresi
copi
number
replicon
rna
determin
direct
comparison
intern
standard
replicon
rna
express
level
express
number
total
rna
sampl
run
triplic
averag
valu
copi
number
employ
quantifi
replicon
rna
